All posts by imreal

Relapsing Polychondritis Foundation Renews Partnership with NYU Grossman School of Medicine to Invest in Next Phase of VEXAS Research


News Image

Because of the strong association between VEXAS and RP, we hope to fuel additional discoveries in the genetic causes of disease which will inevitably lead to new and better means of diagnoses and novel therapies.

The Relapsing Polychondritis (RP) Foundation is pleased to announce it will continue and expand its partnership with NYU Grossman School of Medicine to invest in and advance the next phase of collaborative VEXAS research.

Funding from the foundation not only contributed to the discovery of VEXAS syndrome, which pinpointed mutations in the UBA1 gene as the cause of the previously unknown inflammatory disease, but also helped produce valuable research including a recent study published in the Journal of the American Medical Association (JAMA) showing VEXAS to be more common than initially anticipated, afflicting approximately one in 4,000 men and one in 26,000 women over age 50.

David B. Beck, MD, PhD, assistant professor in the Department of Medicine and the Department of Biochemistry and Molecular Pharmacology at NYU Langone Health and director of NYU Langone’s clinical Inflammatory Disease Genetics Program, will continue to lead his laboratory and clinical program team with the aim of providing genetic diagnoses for individuals with unexplained, severe inflammatory disease, better understanding the mechanism of VEXAS syndrome, and finding treatments to help patients with VEXAS syndrome and RP, as more than half of patients with VEXAS meet diagnostic criteria for RP.

“We are thrilled to grow our partnership with the Relapsing Polychondritis Foundation. Support from the RP Foundation has fueled our discoveries to date, and we are both committed to improving outcomes for people suffering from VEXAS and related autoimmune diseases. We are grateful for the foundation’s efforts to educate the public about these diseases and raise funds to help find the causes as well as effective treatments,” said Dr. Beck.

“Because of the strong association between VEXAS and RP, we hope to fuel additional discoveries in the genetic causes of disease which will inevitably lead to new and better means of diagnoses and novel therapies. We are optimistic Dr. Beck and his team will continue to have a considerable impact on rheumatology, hematology, and autoimmune research through their work and are proud to be partnering with them for another chapter of our mutual mission,” said David Bammert, President of the RP Foundation.

For more information about relapsing polychondritis, the RP Foundation, and the Race for RP, please visit https://www.polychondritis.org and https://raceforrp.org. For all general and media inquiries, please contact David Bammert at (906) 869-3962 or dbammert@polychondritis.org.

About the Relapsing Polychondritis Foundation Inc.

The Relapsing Polychondritis Foundation Inc. is a 501(c)(3) non-profit organization which strives to raise awareness and educate the public, as well as represent its patients to the global medical community and support medical research toward a cure. For more information about the RP Foundation, please visit the foundation’s website.

About Race for RP

Race for RP is a non-profit organization that supports research, awareness programs, and care, for those affected by relapsing polychondritis and related diseases. RP is a painful, debilitating, and sometimes fatal autoimmune disease in which the immune system misfires, turning on the patient’s cartilage. For more information about Race for RP, please visit the organization’s website.

Media Contacts:

Company Name: Relapsing Polychondritis Foundation

Name: David Bammert

Phone: (906) 869-3962

Email Address: Send Email

Website: https://www.polychondritis.org

Share article on social media or email:

Inbound Health Exceeds 5,000 Acute Care-at-Home Episodes in its Partnership with Allina Health


News Image

…Inbound Health brings the capabilities and experience to help our partners address real problems including challenges with inpatient capacity, length of stay increases due to post-acute care bed availability, the total cost of care, and patient experience…

Inbound Health, a company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs, has announced today that their proprietary platform has enabled Allina Health to successfully conduct over 5,000 home-based acute care episodes. Data generated from the 5,000+ historical episodes show that Allina Health is caring for patients with high severity of illness yet achieving outsized clinical outcomes. Since the program’s inception, the average severity of illness score for the home hospital cohort of patients was 24.3% higher than that of the cohort of patients that were referred to a facility-based care setting. At the same time, the program generated a potentially preventable readmissions score of .91, outperforming brick-and-mortar post-acute care settings. The program has generated an average NPS score of 86, demonstrating that patients and their family members prefer this level of care when clinically appropriate.

Through this partnership, Inbound Health provides a wide complement of capabilities required to power this innovative level of care that include home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, logistical oversight, and payer contracting. Allina Health has leveraged this program to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated, and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program. The company’s flexible partnership structure enables Allina Health to leverage its existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across its service area.

“Allina Heath’s home hospital program represents a new level of care – one that provides safe and high-quality care in a more comfortable setting at a lower cost,” said Emily Downing, Allina Health’s Chief Clinical Officer for Population Health. “Our partnership with Inbound Health will enable us to offer Home Hospital Care to more patients throughout Minnesota and to continue to enhance care and service offerings for our Home Hospital care patients. We are excited for what lies ahead of us in this important partnership.”

Inbound Health has proven that the program lowers the total cost-of-care by 30-40% on a risk-adjusted basis while achieving similar or improved clinical outcomes when compared to traditional facility-based care. These outcomes have enabled Inbound Health and Allina Health to develop unique episodic-based payer contracts with multiple Commercial and Medicare Advantage payers in Minnesota, a payment model that the company plans on replicating with partners in other markets.

Blue Cross and Blue Shield of Minnesota was an early supporter of Inbound Health through its network agreement with Allina Health. “We are committed to advancing emerging care models to improve the patient experience and lower the total cost of care,” said Eric Hoag, Vice President of Provider Relations at Blue Cross. “We continue to be excited about offering this new level of care to our members when clinically appropriate and look forward to ongoing collaboration as the model is expanded.”

Inbound Health has successfully cared for patients across 350 different disease states. While the program was developed at the beginning of the COVID-19 pandemic, the vast majority of the patients they serve today, alongside Allina Health, are not COVID-positive. The company is in multiple discussions with other health systems and health plans in different parts of the United States and expects to launch in several new markets over the next year. In addition, over the next year Inbound Health is investing over $10 million in its proprietary technology and analytics platform, which has been developed based on the experience garnered over the past three years.

“We are very proud of the fact that our partnership with Allina Health has delivered safe and high-quality care at a lower total cost,” said Dave Kerwar, CEO of Inbound Health. “Inbound Health brings the capabilities and experience to help our partners address real problems including challenges with inpatient capacity, length of stay increases due to post-acute care bed availability, the total cost of care, and patient experience. We are particularly proud of the fact that alongside Allina Health, we are increasing not just the volume of patients served but also the variety of disease states and referral settings. Over the past year, non-covid admissions have increased by 80%, and admissions from the Emergency Department have grown by 10%. These results demonstrate Inbound’s ability to support scaling health system programs and indicate a strong outlook for hospital-at-home beyond the typical COVID use case.”

To learn more, visit http://www.inboundhealth.com.

About Inbound Health

Inbound Health provides a full stack of capabilities that enables health systems and health plans to offer hospital and skilled nursing facility-level care in the home. With a commitment to quality and compassionate care, Inbound Health has treated over 5,000 patients across 350+ DRGs and counting, and will further customize the care model to the needs and strategies of its partners. Learn more at http://www.inboundhealth.com.

About Allina Health

Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 12 hospitals, 14 retail pharmacies, specialty care centers and specialty medical services that provide home care, senior transitions, hospice care, home oxygen and medical equipment, and emergency medical transportation services. Learn more at allinahealth.org and join us on Facebook and Twitter.

Share article on social media or email:



SightMD Welcomes The Ophthalmic Center To Its Expert Team


News Image

“The founders of SightMD along with their entire organization, align with our clinical mission statement that “patients come first”. Together we are looking forward to continuing our mission and expertise in the greater Long Island area.” said Dr. Basilice

SightMD, a leading multi-specialty ophthalmology platform, today announced a strategic partnership with The Ophthalmic Center (TOC Eye), an eastern Long Island based ophthalmology practice. Through this strategic partnership the practices in East Setauket, 8 Technology Drive East Setauket, NY 11733 and in Wading River, 6144 Route 25A Wading River, NY 11792 will expand SightMD’s presence by adding two location and four providers, growing SightMD’s current footprint to 40+ locations and 85+ providers across New York.

For over 40 years, TOC Eye has been a preferred ophthalmology practice for individuals seeking vision correction and comprehensive eye care throughout eastern Long Island, NY. The talented eye surgeons and optometrists at TOC Eye strive to dramatically improve the quality of life for their patients in East Setauket and Wading River. Thousands of people have trusted their award-winning team with their families’ eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD. The doctors at TOC Eye joining the SightMD team are Vincent P. Basilice, MD, Michael Conners, MD, Alexander Llinas, MD, and Alex Schaffer, OD.

Jeffrey Martin, MD, Co-founder and President of SightMD, said, “I am honored to be partnering with the eye doctors of The Ophthalmic Center. Dr. Basilice is an excellent doctor who has enjoyed an amazing reputation over many years. I look forward to working together to provide the best in care to our patients”.

Jonathan Lujan, CEO of Sight Growth Partners added “Sight Growth Partners is privileged to have the opportunity to be the administrator for TOC Eye where all of the doctors and staff provide the highest quality of eye care to their patients.”

Dr. Basilice, the founder and medical director of TOC Eye, is a board-certified ophthalmologist that has been regarded as one of the best eye surgeons on Long Island for over 40 years. Dr. Basilice is regularly sought out as a community, organizational, and education speaker, addressing a diverse array of ophthalmic topics including glaucoma, macular degeneration, diabetic eye care, and the latest advances in cataract IOL treatment and laser vision correction. Dr. Basilice has been invited to participate in a number of clinical trials including investigation for the multifocal intraocular lens as well as numerous other pharmaceutical test protocols. In addition, Dr. Basilice is recognized as one of the Island’s foremost authorities on LASIK laser vision correction, being among the first on Long Island to regularly include the advanced technologies of WaveScan pre-surgical testing and the capabilities of the VISX Star S4 excimer laser. Dr. Basilice is a Castle Connolly Top Doctor. He received the prestigious Theodore Roosevelt Award and was recognized as The Humanitarian Of The Year in 2015. Dr. Basilice is a Brooklyn native and now resides with his wife Dahna in Suffolk County. Dr. Basilice has stated his excitement to start this new chapter of his medical career with SightMD. When asked about how he feels about joining SightMD Dr. Basilice said “The founders of SightMD along with their entire organization, align with our clinical mission statement that “patients come first”. Together we are looking forward to continuing our mission and expertise in the greater Long Island area.”

Dr. Conners is a Board Certified Ophthalmologist, who brings expertise in the fields of Cornea and External Diseases as well as Refractive Surgery. Dr. Conners is a graduate of Hofstra University and completed his medical and graduate training at New York Medical College resulting in a dual M.D., Ph.D. degree. Dr. Conners completed fellowship training in Cornea, External Diseases and Refractive Surgery both at Washington University and the nationally recognized Minnesota Eye Consultants in Minneapolis. Dr. Conners has extensive experience in routine and complex cataract surgery including the newer multifocal and accommodative lens technology. Dr. Conners is a Long Island native, having grown up in East Meadow and now residing in Miller Place with his wife and has 3 grown children.

Dr. Llinas specializes in the treatment of glaucoma both medically and surgically. His education has been quite extensive, receiving his Bachelor of Arts degree from New York University. He attended St. Andrews University, one of the oldest and most prestigious universities in the United Kingdom, where he received a Ph.D. in molecular biology. Dr. Llinas also received his Medical Doctorate from New York University School of Medicine in Manhattan. Although Dr. Llinas spends most of his time caring for his glaucoma patients, he still finds time to do research in the field. He has given many lectures to very diverse groups and continues to author papers on the subject of glaucoma. Dr. Llinas was born in Chicago, Illinois, but spent most of his life in Manhattan. He has since moved to Long Island, where he resides with his wife and his young children.

Dr. Schaffer earned his doctorate degree in optometry from SUNY Optometry in Manhattan. While obtaining his degree, Dr. Schaffer interned at TOC Eye, The Veterans Hospital in Northport, and at Family Vision Care in San Carlos, California. This training allowed him to work closely with both optometrists and ophthalmologists in treating diseases such as glaucoma and macular degeneration, in addition to fitting contact lenses and providing vision therapy and rehabilitative services to patients. Dr. Schaffer is a member of the American Optometric Association. He is a long time resident of Setauket and a graduate of Ward Melville High School. He is proud to call the Three Villages his home and hopes to provide continuing quality eye-care within the community. Dr. Schaffer resides in South Setauket with his wife, 2 young children and another on the way.

The team of doctors at TOC Eye will continue to care for their patients at the same Wading River and East Setauket offices. With this partnership their patients and the community will have access to seamless care at all of SightMD’s office locations throughout Long Island, Westchester and New York City.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

About Sight Growth Partners

Sight Growth Partners is the leading administrative services provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, marketing, human resources, and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com.

CytoVeris and AdventHealth Central Florida Join Forces for Clinical Study to Improve Prostate Cancer Outcomes


News Image

CytoVeris Inc., a medical device company developing AI-powered cancer imaging technologies to enable more precise surgical decision-making and improve patient outcomes, today announced the start of a new clinical research study to investigate the precision of using an AI-powered imaging device during surgery to improve prostate cancer margin assessment. This device, called MarginASSURE, is expected to provide more precise surgical decision-making in real-time while also improving patient outcomes.

The study, a collaboration between CytoVeris Inc. and AdventHealth Central Florida, will focus on CytoVeris’ multispectral imaging capability for the intraoperative assessment of cancer margin during robotically assisted radical prostatectomy (RARP) surgery.

The study will only involve U.S.-based surgeries at the AdventHeath Celebration facility and will be led by Vipul Patel, M.D., founder and medical director of the Global Robotics Institute at AdventHealth Celebration, and his team. Patel is world-renowned for his contribution to the field of robotic-assisted surgery and is one of the most experienced robotic surgeons in the world, having personally performed over 16,000 robotic prostatectomies.

“We are very excited to extend our technology to help surgeons and their patients undergoing prostatectomy in collaboration with one of the world’s leading surgeons in Dr. Patel and the outstanding team at AdventHealth,” said Patrick Curry, COO of CytoVeris. “Having demonstrated the technology in bladder and breast cancer surgery, this is the next impactful indication for our platform.”

Why it matters:

According to the American Cancer Society, prostate cancer is second only to skin cancer among the most common cancers in American men. This year, it is estimated that the U.S. will see 288,300 new cases of prostate cancer resulting in 34,700 deaths. Among men diagnosed with prostate cancer this year, approximately 90,000 will undergo RARP surgery [1]. Post-surgical positive margin rates are generally only in the 20% range which can lead to complications and poorer patient outcomes [2].

How the device will be used in the study:

During the course of the multi-year study, Patel will collaborate with CytoVeris in adapting and developing its imaging platform for prostate cancer margin assessment.

“In the operating room, every move is critical. Robotic devices are changing the way we (surgeons) operate by providing more precision, therefore better patient outcomes,” Patel said. “This study will attempt to demonstrate the capability of MarginASSURE and its ability to detect cancer in near-real time in a label-free manner through the development of advanced tissue characterization technologies that can identify cancer tissue, assess margins, and identify critical tissue structures.”

The CytoVeris system is based on proprietary Multi-Spectral Tissue Auto-Fluorescence (AF) Imaging technology that analyzes the “optical fingerprint” of tissue due to its intrinsic biomolecular and morphological characteristics, without the use of dyes or imaging agents.

The prostate imaging device, named MarginASSURE, is designed to provide rapid margin assessment of excised prostate specimens and deliver to the surgeon actionable data to help guide the surgical steps required to better optimize patient outcomes, while also optimizing nerve sparing.

The project work will incorporate and correlate pre-operative MRI imaging of tumors with the MarginASSURE imaging of RARP specimens suspect of extraprostatic/extracapsular extension of cancer into the periprostatic soft tissues.

“CytoVeris was founded on the vision that, by leveraging advanced optical imaging and artificial intelligence, surgeons will have the ability to visualize cancer when it matters most – in the operating room,” said Dr. Alan D. Kersey, Ph.D., president & CEO of CytoVeris. “This clinical research study aims to demonstrate and validate our technology in prostate cancer, opening doors to further optimize patient outcomes.”

About CytoVeris:

Based in Farmington CT, CytoVeris is a medical device manufacturer developing AI-powered imaging technology for real-time ex-vivo tissue visualization and identification, enabling more precise intraoperative decisions, leading to improved patient outcomes and reducing unnecessary repeat procedures. Our intraoperative imaging platform, based on a proprietary Multi-Spectral Tissue Auto-Fluorescence Imaging (MS-TAFI) system and powered by AI-based machine learning algorithms, analyzes the “optical fingerprint” of the tissue corresponding to its intrinsic biomolecular and morphological characteristics, without the use of dyes or imaging agents.

For more information, visit http://www.cytoveris.com

About the AdventHealth Central Florida Division:

AdventHealth’s Central Florida Division encompasses more than 20 hospitals and ERs in the six counties in and surrounding metro Orlando. The world-class hospitals, combined with a comprehensive outpatient care network, see more than 5.7 million patient visits annually.

AdventHealth also has an expansive research portfolio in Central Florida, with more than 500 clinical trials and studies in progress.

The organization has a deep commitment to serving the community and has a local financial impact of more than $1 billion annually. AdventHealth and its employees are responsible for nearly 20 percent of Central Florida’s economy.

The division’s flagship campus — AdventHealth Orlando — boasts nationally and internationally recognized programs and serves as a major tertiary and quaternary referral hospital for much of the Southeast, the Caribbean and Latin America. Quality specialty care is provided through AdventHealth Institutes, which is nationally recognized in numerous specialties.

AdventHealth Orlando has been recognized by U.S. News & World Report, Newsweek, Centers for Medicare and Medicaid Services, and the Leapfrog Group.

Learn more about the Central Florida Division on our Newsroom.

REFERENCES:

1.    Underwood, W., III, Jackson, J., Wei, J.T., Dunn, R., Baker, E., DeMonner, S. and Wood, D.P. (2005), Racial treatment trends in localized/regional prostate carcinoma: 1992–1999. Cancer, 103: 538-545. https://doi.org/10.1002/cncr.20796

2.     Iczkowski KA, Lucia MS. Frequency of positive surgical margin at prostatectomy and its effect on patient outcome. Prostate Cancer. 2011;2011:673021. doi: 10.1155/2011/673021. Epub 2011 Jun 9. PMID: 22110996; PMCID: PMC3200270.

Professional Physical Therapy Announces New Clinic Opening in Cresskill, NJ


Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New Jersey, Connecticut, Massachusetts, and New Hampshire, announces the opening of a new clinic in Cresskill, NJ. The 3,000 square foot facility includes a large rehabilitation space with state-of-the-art equipment for patients.

The new clinic is located at 300 Knickerbocker Road, right across from the Camp Merritt Memorial circle at the intersection of Knickerbocker Road and Madison Avenue. It was opened under Professional’s strategic partnership program that provides a unique affiliation solution to clinicians and leaders who are vested in ownership and operations. Even more patients in New Jersey will have greater access to the clinical expertise and cutting-edge therapeutics offered by Professional.

The clinic will be led by Clinical Director Partner, Purvang Kapadia, PT, MS, DPT, OCS. Purvang is excited to open in Cresskill and adds, “I am thrilled to partner with Professional PT to bring expertise and a patient first attitude to Cresskill and help serve the local community to lead an active, pain free life. I look forward to providing an exceptional client experience and be part of a thriving culture.”

Services available at Professional Physical Therapy in the Cresskill clinic include:

  • Physical Therapy – Our physical therapists treat medical conditions that limit functional mobility and help develop a customized treatment plan to improve the ability to move, reduce pain, restore function, and prevent disability.
  • TMJ Therapy – If you are experiencing jaw pain our physical therapists can provide a treatment plan to strengthen and stretch the muscles in your face to reduce pain and discomfort.
  • Vestibular Therapy – We have specialists that can design an exercise-based treatment plan to help reduce feeling of vertigo or dizziness and improve balance and coordination.
  • Free Injury Screens – If you have an ache, pain, performance issue, or question, you can schedule a 1-on-1 session with one of our physical therapists. We evaluate your condition to help recommend which treatments may be effective, including making a referral if a specialist is advised.


Additionally, the Cresskill clinic:

  • Accepts most major insurance plans.
  • Offers convenient hours, including early mornings and late evenings.
  • Does not require a physician referral or prescription to start treatment.
  • Schedules each initial evaluation quickly, sometime the same or next day.
  • Provides ongoing patient education on diagnosis, treatment plans and prescribed home-exercise programs.


Professional Physical Therapy currently operates widely across five of the Northeast states. For more information and a list of all Professional Physical Therapy locations and services, please visit http://www.professionalpt.com

About Professional Physical Therapy

Professional Physical Therapy was founded in 1999 and is an industry leader, providing private outpatient physical and hand therapy services throughout the Northeast. Our clinical team is comprised of multi-specialty Physical, Hand and Occupational Therapists who can treat a wide variety of orthopedic injuries and conditions with excellence. Today, Professional has grown to include over 190 facilities in New York, New Jersey, Connecticut, Massachusetts, and New Hampshire.

Share article on social media or email:

Injecting Transparency into Healthcare, RefMed Launches Three Products to Provide Accurate Medical Pricing Data for All Medical Procedures


News Image

Our mission is simple, improve healthcare financial outcomes by providing the most accurate, unbiased, and timely pricing information to providers, payers, and patients

RefMed, the first provider of market-referenced pricing for the Healthcare Industry, is launching three products delivering pricing transparency to physicians, insurance companies, bill review companies, government agencies, and patients.

Physician Price Intel delivers accurate, unbiased, and timely market-based pricing for physicians regardless of their specialty. Using proprietary algorithms and trillions of records, RefMed cross-references pricing for all procedures with other providers in the same geo-code.

TrueUCR is the first usual and customary fee schedule based on actual contract amounts from public and private payers. RefMed has accumulated trillions of records and produced a range of acceptable prices for every procedure code in every part of the country.

TrueFee is an innovative market-based approach to creating medical fee schedules for government agencies.

“Our mission is simple, improve healthcare financial outcomes by providing the most accurate, unbiased, and timely pricing information to providers, payers, and patients,” said Todd McDaniel, RefMed President & CEO. “We believe a market works best when accurate pricing is transparent to everyone.”

By compiling, aggregating, and analyzing actual contracted market rate data across all procedures by zip code, RefMed will be the healthcare industry’s most accurate and meaningful database for Payors, Providers and Consumers of medical services in the United States.

“A lack of transparency is a primary contributor to increases in healthcare pricing across the board,” said McDaniel. “Using our proprietary data, we can provide a truly ‘Market Referenced’ pricing solution that will address the issues facing the healthcare industry today around accuracy, consistency and overall fairness of actual costs associated with medical spend; specifically addressing costs by treatment code, by geo-code, and by provider, all based on the actual contract rate data. Think of it as the Kelly Blue Book for healthcare.”

RefMed Benefits to Customers:

  • Allows physicians and hospitals to negotiate contract rates with insurance companies.
  • Allows third party administrators to negotiate contracts and fees for specific out of network services.
  • Allows insurance companies and bill review companies to determine an appropriate reimbursement amount when no contract is in place.
  • Allows federal and state agencies to set fee schedules for government paid services.
  • Allows patients to shop for future services or negotiate prices for uncovered or out of network services.
  • Allows economists and research institutions to track the cost of healthcare over time by region, type of service, and payment types.

For more information about RefMed and its industry changing products and services visit https://refmed.com/

About RefMed: RefMed is an independent company with no affiliation to any insurance company or physician association. We are a team of healthcare consultants, data scientists, and developers with many years of experience in both public and private payer insurance business. We have experienced the frustration of usual and customary pricing that is neither usual or customary and we wanted to find a better way.

Media Contact: Colin Trethewey, PRmediaNow Communications: Colin@PRmediaNow.com

Share article on social media or email:

Embark Behavioral Health Adds Premier Outpatient Clinic in Scottsdale


New Embark Behavioral Health Outpatient Clinic in Scottsdale, AZ

“The new Scottsdale outpatient center, along with our existing Phoenix location, will be a catalyst for healing in the Valley and a window into Embark’s spectrum of services,” said Alex Stavros, CEO of Embark Behavioral Health.

Embark Behavioral Health, a leading network of mental health treatment programs for preteens, teens, young adults, and their families, will soon add a Scottsdale outpatient therapy clinic to its services in the Phoenix area. The clinic is enrolling clients and will feature an intensive outpatient program (IOP) and a therapeutic day treatment program (also known as a partial hospitalization program, or PHP) as part of the company’s robust continuum of care.

“The new Scottsdale outpatient center, along with our existing Phoenix location, will be a catalyst for healing in the Valley and a window into Embark’s spectrum of services,” said Alex Stavros, CEO of Embark Behavioral Health. “Our teammates have done an exceptional job launching these programs and bringing the Embark treatment approach to families across the greater Phoenix area. And with suicide being the second-leading cause of death for ages 10-24 in Arizona, it’s more important than ever that we create access to higher quality mental health services.”

The clinic, located at 7373 N. Scottsdale Road, Suite D-120, in Scottsdale’s McCormick Ranch area, will be the second Embark location offering outpatient treatment programs in Arizona, with Uptown Phoenix being the first.

Embark ensures the highest levels of quality care and safety standards, offering programs accredited by The Joint Commission. Programs include individual, group, and family therapy, as well as therapeutic/peer mentoring, home health care services, addiction treatment, and parent coaching for issues such as:

  • Attention-deficit/hyperactivity disorder (ADHD) 
  • Anger/mood regulation 
  • Anxiety 
  • Bipolar disorder 
  • Borderline personality disorder
  • Bullying 
  • Depression 
  • Family conflict 
  • Self-harm/cutting 
  • Social isolation 
  • Substance use/abuse 
  • Technology addiction

The Scottsdale Clinic: A Closer Look

“The new Scottsdale clinic will help more adolescents and young adults to maintain and thrive in their lives and relationships through the support of professional mental health counseling,” said the location’s executive director, Dr. Meka Allen, who has a doctorate in social work. “I’m excited to bring our unique family-centered treatment approach to those in need in our area.”

Embark treats the family as a whole, using an evidence-based and relationship-focused approach. In addition to providing family therapy, the company also collects thousands of data points and shares feedback with each family so it can adjust treatment in real time to improve results.

The Scottsdale location’s therapists will serve a variety of locations throughout Phoenix, including:

  • Scottsdale
  • Tempe
  • Mesa
  • Chandler
  • Glendale
  • Phoenix
  • Paradise Valley
  • Fountain Hills
  • Windsong
  • Ahwatukee
  • Guadalupe
  • Gilbert
  • Queen Creek
  • Camelback East Village
  • Desert Ridge
  • Tolleson
  • Goodyear
  • South Mountain
  • Apache Junction
  • Avondale

To celebrate, Embark will host an open house and ribbon-cutting ceremony with the Scottsdale Chamber of Commerce from 4:30 to 6:30 p.m. on March 30. Guests will enjoy refreshments, learn about the intensive outpatient and therapeutic day treatment programs, and tour the new space. To RSVP for the event, visit: https://www.eventbrite.com/e/open-house-ribbon-cutting-ceremony-at-embarks-scottsdale-clinic-tickets-574957783207

In addition to increasing the number of families it serves in the Phoenix area, recent Embark milestones include:

  • Expanding the company’s online mental health services with an insurance-reimbursed available to residents in various states across the country.
  • Moving the Embark Behavioral Health support office to Chandler, Arizona. The vibrantly designed space celebrates the company’s culture, values, and purpose.
  • Opening several insurance-reimbursed short-term residential and outpatient clinic locations across the country in states including California, Colorado, Maryland, Georgia, and Virginia.
  • Launching the Embark Behavioral Health Foundation with a mission to raise awareness of the youth mental health crisis, end the stigma around mental illness, and drive more access to high-quality services. The foundation will also provide a scholarship fund to help adolescents, young adults, and their families participating in mental health services pay for private pay programs, insurance co-pays, premiums, and general fees.

For more information about Embark Behavioral Health, visit http://www.embarkbh.com.

ABOUT EMBARK BEHAVIORAL HEALTH

Embark Behavioral Health is a leading network of outpatient centers and residential programs offering premier mental health treatment for preteens, teens, and young adults. Dedicated to its big mission of reversing the trends of teen and young adult anxiety, depression, and suicide by 2028, Embark offers a robust continuum of care with different levels of service and programming; has a deep legacy of over 25 years serving youth; works with families to adjust treatment in real time to improve results; treats the entire family using an evidence-based approach; and offers the highest levels of quality care and safety standards. For more information about Embark or its treatment programs, including virtual counseling, intensive outpatient programs (IOPs), therapeutic day treatment programs, also known as partial hospitalization programs (PHPs), short-term residential treatment, wilderness therapy, and long-term residential treatment, visit http://www.embarkbh.com.

Share article on social media or email:

Fort Myers Men’s Clinic Expands to Naples, FL with New Location: Naples Men’s Clinic


Naples Mens Clinic

“Our goal is to provide the highest quality of care to our patients and help them achieve the best results possible.”

Fort Myers Men’s Clinic is excited to announce the expansion of their business to Naples, FL with the opening of the new Naples Men’s Clinic located on 4081 Tamiami Trail. Due to the recent growth and demand for services in the area, Fort Myers Men’s Clinic has decided to expand their services to better serve the men of Naples and surrounding areas.

The new Naples Men’s Clinic will offer a wide range of men’s health related services including treatment for erectile dysfunction, low testosterone, hair restoration, and Peyronie’s disease. The clinic will also offer an Intimacy Guarantee which is unique to the industry, ensuring that patients only pay if they receive the desired results. Additionally, the clinic will provide same-day results for Low Testosterone and hormone treatments, providing patients with quick and efficient service.

CEO, Shauli Greenspan expressed his excitement for the expansion, stating: “We are thrilled to be able to bring our services to the men of Naples and surrounding areas. Our goal is to provide the highest quality of care to our patients and help them achieve the best results possible. With the opening of the new Naples Men’s Clinic, we will be able to expand our reach and continue to provide top-notch medical care to those in need.”

The Naples Men’s Clinic will offer the latest advancements in medical technology to treat erectile dysfunction, including acoustic-wave therapy, such as Pulse ED. These treatments have been shown to be highly effective in treating erectile dysfunction and have been widely adopted by medical professionals across the country.

“We believe that every man deserves to feel confident and healthy,” added Greenspan. “We are dedicated to providing our patients with the best possible care and treatment options to help them achieve their goals. With the opening of the new Naples Men’s Clinic, we are excited to be able to offer our services to even more men in need.”

The Naples Men’s Clinic is now open and accepting new patients. Those interested in learning more about the clinic’s services can visit their website at https://www.naplesmensclinic.com or call to schedule a FREE, no-obligation appointment with the provider. With their commitment to patient care and satisfaction, the Naples Men’s Clinic is sure to become a valuable resource for men’s health in the Naples area.

Call 239-317-7777 for the Fort Myer’s Mens Clinic or 239-367-7000 for the Naples Men’s Clinic. Now located at 4081 Tamiami Trail. N. STE 203, Naples, FL 34103.

Share article on social media or email:

Eva Carlston Academy Announces Acceptance and Commitment Therapy Continued Education for Entire Clinical Team


News Image

I feel like ACT really allows the client to separate parts of themselves to alleviate shame and guilt. This will be useful for our students to learn to let go of or accept parts of them and embrace the successful parts of themselves.

Eva Carlston Academy in Utah is proud to announce the successful completion of a thirteen-hour continued education course on Acceptance and Commitment therapy. The in-person course, led by Expert ACT Clinician, Robyn Walser, taught the clinical team how to apply acceptance and commitment therapy to their therapeutic process.

Each member of the Eva Carlston Academy team took something special from the continuing education seminar.

“I learned how to utilize the 6 core principles of ACT to create psychological flexibility where the therapist and client utilize mindfulness and behavior-changing strategies to treat depression, anxiety, ADHD, and trauma. Issues which are the core of my work.” -Stacy Fenton, CSW

“The focus of Acceptance and Commitment Therapy (ACT) is the therapeutic alliance. Therapist and client can create a vital collaborative experience through the utilization of the principles of diffusion, choice, perspective-taking, and values. I am excited to use this more in sessions with my client’s to give them more accountability and responsibility.” – Hannah Mecham, CSW

“I feel like ACT really allows the client to separate parts of themselves to alleviate shame and guilt. This will be useful for our students to learn to let go of or accept parts of them and embrace the successful parts of themselves.” Lisa Gaffney-Gonzalez, LCMHC, SUDC

“ACT helps individuals to accept their emotions and their thoughts rather than fighting them and feeling guilty for them. The act of acceptance will help them decrease unnecessary suffering and increase self-compassion and ability to shift into empowerment, helping them create a rich and meaningful life.” Sydney Haga, CMHC

Eva Carlston Academy remains committed to implementing clinical best practices, so

they can offer the finest possible service for its students.

Those interested in learning more about Eva Carlston Academy can visit https://evacarlston.com/

About Eva Carlston Academy:

At Eva Carlston Academy, adolescent girls who have struggled deeply are invited to find their unique place in the world, a passion to inspire and guide them, and a sense of purpose in life. A combination of sophisticated therapy, mentorship, the arts, and experiential learning help the students of Eva Carlston Academy heal and grow.

Share article on social media or email:

DynamiCare Health Digital Therapeutic Receives FDA Breakthrough Device Designation for Treatment of Alcohol Use Disorder


DynamiCare Health Inc., a digital therapeutics company dedicated to helping people overcome addiction, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for DCH-002, a prescription-only digital therapeutic intended to treat alcohol use disorder (AUD).

The Breakthrough application was based on a randomized control trial funded by the National Institutes of Health and published by an external team of researchers from Johns Hopkins University School of Medicine. The study demonstrated that patients randomized to receive DCH-002 as part of outpatient AUD treatment were 8 times more likely to remain in treatment past 90 days and had verified abstinence rates twice as high as controls.

Over 29 million Americans suffer from AUD. Every year – even accounting for exponential increases in drug poisoning deaths – more Americans die from AUD-related complications than drug overdoses. There is a major gap in care: 90% of people with AUD do not receive any treatment. Even among those who do seek and receive treatment, attrition is alarmingly high – 73% of patients drop out by month five. DCH-002 offers an evidence-based technology solution designed to help adults living with AUD to reduce or cease their consumption of alcohol and dramatically improve outcomes and retention in treatment.

There are FDA-approved medications to treat AUD, such as naltrexone (Revia and Vivitrol), disulfiram (Antabuse), and acamprosate. These medications, however, are utilized by only 22% of individuals in treatment for AUD. DCH-002 is designed to increase access to care by offering patients a highly effective intervention with the convenience and privacy of remote care and without side effects or contraindications (e.g., pregnancy or liver disease). As a digital therapeutic, DCH-002 is expected to have a low risk profile and can be used in conjunction with medication or other psychosocial treatments, when cleared by the FDA for marketing.

Like other DynamiCare products, DCH-002 implements a long-established therapeutic methodology called contingency management, in which patients earn financial incentives for achieving abstinence from addictive substances. DCH-002 combines a smartphone app with a Bluetooth-connected, police-grade breathalyzer, and a reloadable, risk-protective smart debit card. Participants complete random breath tests to measure Blood Alcohol Content (BAC) through the app, validated over selfie video. If they test negative, they earn financial rewards on the smart debit card, which blocks access to bars, liquor stores, and cash withdrawals. DCH-002 also includes a library of self-guided therapy modules based on cognitive behavioral therapy (CBT), teaching skills such as how to deal with stress, triggers, and cravings.

“We know that contingency management helps in the treatment of alcohol use disorder,” said Laura E. Kwako, PhD, Chief of the Treatment, Health Services, and Recovery Branch at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). The DynamiCare FDA Breakthrough Designation is based upon research funded by a Small Business Innovation Research grant from NIAAA.

“I’m proud to support DynamiCare because their platform is advancing evidence-based treatments that the field desperately needs,” said former U.S. Rep. Patrick J. Kennedy, a DynamiCare Health investor and advisor.

“It’s clear the field of alcohol use disorder treatment is in need of new solutions when only 10% of people with the condition seek and receive treatment, and only a quarter of those stay engaged past 5 months,” said Eric Gastfriend, CEO of DynamiCare Health. “Our mission is to automate best practices so that addiction treatment becomes more accessible, engaging, and effective. Our product could become the first FDA-approved digital therapeutic for alcohol use disorder, and we are honored that FDA has recognized DCH-002 as a medical breakthrough.”

DynamiCare has received a$1.6M grant from NIAAA to conduct a multi-site, 12-month randomized controlled trial of DCH-002, which is currently underway.

The FDA Breakthrough Devices Program is intended for devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. Breakthrough designation will now allow DynamiCare Health to interact with the FDA through an expedited and prioritized process towards the marketing of DCH-002.

This is the second FDA Breakthrough Device Designation for DynamiCare. The company previously received the designation for DCH-001, its technology for treatment of smoking cessation in pregnancy.

For more information: https://www.dynamicarehealth.com/our-results

About DynamiCare Health

DynamiCare Health is a digital therapeutics company dedicated to helping people overcome addiction. The company’s digital health platform automates contingency management, an evidence-based system for rewarding healthy behavior that has been demonstrated to be effective in over 100 randomized controlled trials. Through encouragement and accountability, DynamiCare members achieve healthy goals with stimulants, opioids, alcohol, and tobacco. For more information, visit http://www.dynamicarehealth.com.

Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number R43AA026234. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

REFERENCES

Hammond A, Sweeney MM, Chikosi TU, Stitzer ML. Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health. Journal of Substance Abuse Treatment. 2021. doi:10.1016/j.jsat.2021.108425

Share article on social media or email: